TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9

被引:0
作者
Bowen Li
Liying Mu
Yanan Li
Kangkai Xia
Yuxi Yang
Sattout Aman
Bashir Ahmad
Shujing Li
Huijian Wu
机构
[1] Dalian University of Technology,School of Bioengineering & Key Laboratory of Protein Modification and Disease, Liaoning Province
来源
Cancer Cell International | / 21卷
关键词
TIMELESS; MMP9; Invasion; Metastasis; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is the first killer leading to female death, and tumor metastasis is one of the important factors leading to the death of patients, but the specific mechanism of breast cancer metastasis is not very clear at present. Our study showed that overexpression of TIMELESS could significantly inhibit the invasion and metastasis of breast cancer cells ZR-75-30 and the assembly of F-actin protein. On the contrary, knockdown of TIMELESS promoted the invasion and metastasis of breast cancer cells. Further study revealed that TIMELESS overexpression decreased the mRNA and protein levels of MMP9. Furthermore, TIMELESS could interact with p65, leading to repress the association of p65 and its acetyltransferase CBP and down-regulating the acetylation level of p65, which inhibited the activation of NF-κB signal pathway. In conclusion, our research showed that TIMELESS may repress the invasion and metastasis of breast cancer cells via inhibiting the acetylation of p65, inhibiting the activation of NF-κB, thus down-regulating the expression of MMP9, and then inhibiting the invasion and metastasis of breast cancer cells.
引用
收藏
相关论文
共 243 条
[1]  
DeSantis CE(2019)Breast cancer statistics, 2019 CA Cancer J Clin 69 438-451
[2]  
Ma J(2013)Shift work, circadian gene variants and risk of breast cancer Cancer Epidemiol 37 606-612
[3]  
Gaudet MM(2003)MT1-MMP and MMP-7 in invasion and metastasis of human cancers Cancer Metas Rev 22 145-152
[4]  
Newman LA(2004)Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells Clin Cancer Res 10 3422-3428
[5]  
Miller KD(2013)Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade Crit Rev Biochem Mol Biol 48 222-272
[6]  
Goding SA(2010)Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141 52-67
[7]  
Jemal A(2009)Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication Pathol Res Pract 205 709-715
[8]  
Siegel RL(1996)Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9 J Clin Oncol 14 3133-3140
[9]  
Grundy A(2007)Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer Gynecol Oncol 104 296-303
[10]  
Schuetz JM(2008)Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database Ann Oncol 19 1566-1572